Dengue Fever Global Clinical Trials Review, H2, 2017

2017-07-26
Price :
Published : Jul-2017
No. of Pages : 105

Dengue Fever Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Dengue Fever Global Clinical Trials Review, H2, 2017” provides an overview of Dengue Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Dengue Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

IDT Biologika GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary IDT Biologika GmbH (IDT Biologika), a subsidiary of Klocke Pharma-Service GmbH, is a manufacturer of vaccines and bio-pharmaceuticals products. It offers services which include integrated development and manufacturing services in four major areas of animal health, vaccines, pharmaceuticals and quality control. The company develops, manufactures and markets pharmaceutical products such as sterile, injectable and bio-engineered finished products. IDT Biologika handles manufacturing and quality control processes which include bulk active substances, sterile filling, packaging systems, cold chains, early development, small-batch production of samples and large-scale production. It has operational presence in the US and Germany. The company partners with biotechnology and pharmaceuti......
$250

Eris Lifesciences Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Eris Lifesciences Ltd (Eris Lifesciences) is a pharmaceutical company that manufactures and commercializes generics products. The company through its divisions provides wide range of products including Maxum, Decal, Eritel H, Eritel CH 80 LS, Glimisave Max Forte 1, Mac Rabonik Plus, Vomisave Syrup, Nikomox CV Dry Syrup and others. Eris Lifesciences offer products in the therapeutic areas of cardiology, gastroenterology, orthopedics and diabetes. It offers products in the form of tablets, syrups and capsules. The company has its manufacturing facility located at Assam, India. Eris Lifesciences is headquartered in Ahmedabad, Gujarat, India. Eris Lifesciences Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of th......
$250

National Heart Lung and Blood Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary National Heart Lung and Blood Institute (NHLBI), a subsidiary of National Institutes of Health is a medical research institute that provides treatment for heart, lung, and blood diseases.The institute conducts research studies with patients who have diseases of heart and blood vessels, lungs, blood cells and bone marrow, and cholesterol. It develops health education and awareness programs to effect positive change in public health. NHLBI operates different divisions for cardiovascular sciences, lung diseases, blood diseases and resources;and a division for intramural research and division for application of research discoveries. The institute works in collaboration with patients, scientists, professional societies, health care professionals, community organizations, and patient ......
$250

Concordia International Rx UK Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Concordia International Rx UK Ltd (Concordia International), formerly Amdipharm Mercury Company Ltd, a subsidiary of Concordia International Corp, is a manufacturer of pharmaceutical products and orphan drugs. The company's products include acetazolamide, adenosine, adrenaline acid tartrate, alfacalcidol, aminophylline, ampres, anturn, apresoline, argipressin, atropine sulfate, baratol, bipuvacaine and carbimazole, among others. It offers its products in various formulations such as tablets, injectables, eye drops and ointment. Concordia International markets its products through a network of distributors. The company operates through its offices in India, Ireland, the UK, Sweden, Dubai and Australia. Concordia International is headquartered in London, the UK. Concordia Inter......
$250

Trovagene Inc (TROV) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Trovagene Inc (Trovagene) is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary molecular genetic detection technologies for screening and monitoring cancer and other diseases. Its product portfolio includes liquid biopsy tests that provide important clinical information about mutations associated with common solid tumor cancers such as colorectal, melanoma, pancreas and lung cancer. These tests are used by physicians, third party clinical laboratories and pharmaceutical companies. Trovagene uses its proprietary Precision Cancer Monitoring (PCM) technology to detect and monitor circulating tumor DNA (ctDNA) in urine and blood for the detection and quantitation of oncogene mutations and improvement in cancer care. Tro......
$250

Kyoto University – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Kyoto University (Kyoto) is a research university that offers educational services. The university provides multi disciplinary courses to students of Japan including medicine, engineering, law, letters, and science. It offers medical services, and diagnoses and treats various health problems in the fields of psychiatry, dermatology, ophthalmology, internal medicine, otolaryngology, and sports orthopedic medicine. Kyoto conducts research programs on fetal brain development in chimpanzees, cerebral development in chimpanzees, and others. The university operates through faculties, graduate schools, research institutes, and research and educational centers. It operates in China, Indonesia, India, Thailand, Singapore, Malaysia, Peru, Ethiopia, Vietnam, the US, the UK, Zambia, Kenya, ......
$250

Innate Pharma SA (IPH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Innate Pharma SA (Innate Pharma) is a healthcare products provider that develops immunopharmacology and antibody technology products. The company carries out the discovery and development of therapeutic antibodies for the treatment of cancer and inflammatory diseases. It develops new monoclonal antibodies that targets receptors and pathways in controlling the activation of innate immunity cells. The company's pipeline products comprise lirilumab, monalizumab, IPH4102, IPH4301, IPH52, IPH53 and IPH33. It has collaborations and partnerships with academic laboratories, clinical centers and industrial leaders. It Innate Pharma is headquartered in Marseille, France. Innate Pharma SA (IPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data ......
$250

Glycotope GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Glycotope GmbH (Glycotope) is a biopharmaceutical company that develops immuno-oncology products for the treatment of various types of cancer. The company's expression platform offers proprietary technologies such as Glycobody (GET) and GlycoExpress(GEX) that allows the glycosylation of antibodies & glycoproteins in human metabolism. These are also used to develop treatments for infertility and blood coagulation disorders. Its oncology pipeline products are used for various cancers including ovarian, breast, lung, head and neck, gastric, non-small cell lung cancer (NSCLC) and others. Glycotope's non oncology pipeline products are used for in-vitro fertilization (IVF), Haemophilia and other indications. The company has offices at Berlin and Heidelberg. Glycotope is headquartered ......
$250

Hydra Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Hydra Biosciences Inc (Hydra) is a biopharmaceutical company that develops novel drugs. The company's pipeline candidate HX-100 is developed to treat diabetic neuropathy and allergic asthma. It offers other drugs for the therapeutic areas including inflammation, pain, renal, anxiety and pulmonary disease. Hydra provides products for dermatological disorders such as pruritus and psoriasis. The company develops transient receptor potential that offers drug discovery opportunities in multiple areas of human disease. Its screening platforms and integrated pharmacology and chemistry infrastructure enable the company to identify and develop drug candidates for various health conditions. The company's ion channels provides the potential to develop selective and safer ion channel drugs.......
$250

PharmaEssentia Corp (6446) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PharmaEssentia Corp (PharmaEssentia) is a research and development company that develops therapeutic products for the treatment of human diseases. The company's pipeline product include P1101, a new generation PEG-Interferon-alpha-2b which is developed using PEGylation technology platform. Its pegylation technology platform is designed to increase the protein drug's efficacy by prolonging its circulation in the bloodstreamd. PharmaEssentia's products can be used in the therapeutic areas of dermatology, hematology, infectious diseases, and oncology. The company also provides contract research and development, and clinical trial services. It collaborates with biotechnology companies, university research institutes, and pharmaceutical companies. PharmaEssentia is headquartered in T......
$250